Cargando…

Identification of 15 novel risk loci for coronary artery disease and genetic risk of recurrent events, atrial fibrillation and heart failure

Coronary artery disease (CAD) is the major cause of morbidity and mortality in the world. Identification of novel genetic determinants may provide new opportunities for developing innovative strategies to predict, prevent and treat CAD. Therefore, we meta-analyzed independent genetic variants passin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verweij, Niek, Eppinga, Ruben N., Hagemeijer, Yanick, van der Harst, Pim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459820/ https://www.ncbi.nlm.nih.gov/pubmed/28584231 http://dx.doi.org/10.1038/s41598-017-03062-8

Ejemplares similares

Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease
por: van der Harst, Pim, et al.
Publicado: (2018)

Relationship of Arterial Stiffness Index and Pulse Pressure With Cardiovascular Disease and Mortality
por: Said, M. Abdullah, et al.
Publicado: (2018)

The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA)
por: Haver, Vincent G, et al.
Publicado: (2014)

Genetic risk and atrial fibrillation in patients with heart failure
por: Kloosterman, Mariëlle, et al.
Publicado: (2020)

Risk prediction of atrial fibrillation in the community combining biomarkers and genetics
por: Börschel, Christin S, et al.
Publicado: (2021)

Associations of Observational and Genetically Determined Caffeine Intake With Coronary Artery Disease and Diabetes Mellitus
por: Said, M. Abdullah, et al.
Publicado: (2020)

Impact of atrial fibrillation on the risk of major adverse cardiac events following coronary revascularisation
por: Jung, Richard G, et al.
Publicado: (2022)

Atrial fibrillation and left atrial size and function: a Mendelian randomization study
por: van de Vegte, Yordi J., et al.
Publicado: (2021)

ukbpheno v1.0: An R package for phenotyping health-related outcomes in the UK Biobank
por: Yeung, Ming Wai, et al.
Publicado: (2022)

Genome-wide association studies of atrial fibrillation: Finding meaning in the life of risk loci
por: Sutanto, Henry, et al.
Publicado: (2019)

Recurrent event survival analysis predicts future risk of hospitalization in patients with paroxysmal and persistent atrial fibrillation
por: Schroder, Jakob, et al.
Publicado: (2019)

Telomere length and incident atrial fibrillation – data of the PREVEND cohort
por: Siland, Joylene E., et al.
Publicado: (2017)

Fine Fibrillatory Wave as a Risk Factor for Heart Failure Events in Patients With Atrial Fibrillation: The Fushimi Atrial Fibrillation (AF) Registry
por: Kawaji, Tetsuma, et al.
Publicado: (2022)

Cluster Individuals Based on Phenotype and Determine the Risk for Atrial Fibrillation in the PREVEND and Framingham Heart Study Populations
por: Rienstra, Michiel, et al.
Publicado: (2016)

Correction to: Fine Fibrillatory Wave as a Risk Factor for Heart Failure Events in Patients With Atrial Fibrillation: The Fushimi Atrial Fibrillation (AF) Registry
Publicado: (2022)

Genetic study links components of the autonomous nervous system to heart-rate profile during exercise
por: Verweij, Niek, et al.
Publicado: (2018)

Heart Rate Recovery 10 Seconds After Cessation of Exercise Predicts Death
por: van de Vegte, Yordi J., et al.
Publicado: (2018)

The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
por: Santema, Bernadet T., et al.
Publicado: (2019)

Sleep Apnea and the Risk of Atrial Fibrillation Recurrence: Structural or Functional Effects?
por: Gottlieb, Daniel J.
Publicado: (2014)

Shifts in gut microbiome and metabolome are associated with risk of recurrent atrial fibrillation
por: Li, Jing, et al.
Publicado: (2020)

Clustering of Unhealthy Lifestyle and the Risk of Adverse Events in Patients With Atrial Fibrillation
por: Lee, So-Ryoung, et al.
Publicado: (2022)

Coronary Endothelial Dysfunction Is Associated With Increased Risk of Incident Atrial Fibrillation
por: Corban, Michel T., et al.
Publicado: (2020)

Contributions of Interactions Between Lifestyle and Genetics on Coronary Artery Disease Risk
por: Said, M. Abdullah, et al.
Publicado: (2019)

Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
por: Santema, Bernadet T., et al.
Publicado: (2020)

Genetically-determined body mass index and the risk of atrial fibrillation progression in men and women
por: Siland, J. E., et al.
Publicado: (2021)

Risk Factors of Atrial Fibrillation in Patients with Heart Failure
por: Sarfraz, Alam, et al.
Publicado: (2018)

Longitudinal risk of death, hospitalizations for atrial fibrillation, and cardiovascular events following catheter ablation of atrial fibrillation: a cohort study
por: Ngo, Linh, et al.
Publicado: (2022)

Risk indexation and atrial fibrillation
por: Nguyen, Thanh H., et al.
Publicado: (2019)

Twenty-Five Novel Loci for Carotid Intima-Media Thickness: A Genome-Wide Association Study in >45 000 Individuals and Meta-Analysis of >100 000 Individuals
por: Yeung, Ming Wai, et al.
Publicado: (2021)

Risk Factors for Recurrence of Atrial Fibrillation in Horses After Cardioversion to Sinus Rhythm
por: Decloedt, A., et al.
Publicado: (2015)

Chronic kidney disease and risks of adverse clinical events in patients with atrial fibrillation
por: LI, Si-Tong, et al.
Publicado: (2021)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

Development and validation of a novel risk model for predicting atrial fibrillation recurrence risk among paroxysmal atrial fibrillation patients after the first catheter ablation
por: Li, Guangling, et al.
Publicado: (2022)

New‐Onset Perioperative Atrial Fibrillation After Coronary Artery Bypass Grafting and Long‐Term Risk of Adverse Events: An Analysis From the CORONARY Trial
por: Conen, David, et al.
Publicado: (2021)

Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation or atrial flutter
por: Wybraniec, Maciej T., et al.
Publicado: (2022)

Left ventricular dysfunction in atrial fibrillation and heart failure risk
por: Kuo, Jen‐Yuan, et al.
Publicado: (2020)

Ventricular rate in atrial fibrillation and the risk of heart failure and death
por: Westergaard, Lucas Malta, et al.
Publicado: (2023)

Atrial Fibrillation in Patients with Permanent VVI Pacemakers: Risk Factors for Atrial Fibrillation
por: Cho, Jeong Gwan, et al.
Publicado: (1997)

Risk of Recurrent Bleeding Events in Nonvalvular Atrial Fibrillation Treated with Vitamin K Antagonists: A Clinical Practice Research Datalink Study
por: Alikhan, Raza, et al.
Publicado: (2019)

Aortic Stiffness in Lone Atrial Fibrillation: A Novel Risk Factor for Arrhythmia Recurrence
por: Lau, Dennis H., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3n8gf0qaotlpio5dpc7228oh6b